HKSE:1530

3SBio Inc. · HKSE · Healthcare · HKD · FY for 2025

Figures on this page computed 2026-11-08 13:41 UTC

Last close

n/aHKD

Market data

3.8xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
HKD
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
47.9%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
51.6%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
1.8%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
HKD
- computed

6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

All from 100

lens 2 of 9

Sales

633

2016-12-31 to 2025-12-31100 at the start633

Sales: 100.00 on 2016-12-31 to 632.60 on 2025-12-31, up 533%.

Profit

1,190

2016-12-31 to 2025-12-31100 at the start1,190

Profit: 100.00 on 2016-12-31 to 1190.37 on 2025-12-31, up 1090%.

Shares in issue

96.2

2016-12-31 to 2025-12-31100 at the start96.2

Shares in issue: 100.00 on 2016-12-31 to 96.18 on 2025-12-31, down 4%.

Sales is at 633, Profit is at 1190, Shares in issue is at 96, against 100 in 2016.

Sales is at 633, Profit is at 1190, Shares in issue is at 96, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100633
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Profit, where the first year is 1001,190
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Shares in issue, where the first year is 10096
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY